<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="73267" id="root" date="1996-09-24" xml:lang="en">
<title>USA: Maxim Pharma says to expand leukemia trial.</title>
<headline>Maxim Pharma says to expand leukemia trial.</headline>
<dateline>SAN DIEGO 1996-09-24</dateline>
<text>
<p>Maxim Pharmaceuticals Inc said on Tuesday it planned seek U.S. Food and Drug Administration authorization to move into a Phase III trial of its Maxamine drug in leukemia patients.</p>
<p>It said it would seek permission to expand into a Phase III study in the U.S. and Europe next year.</p>
<p>Phase IIb clinical trial results in acute myelogenous leukemia showed Maxamine extended the duration of remission beyond the length of remission reported for patients in previously published trials using interleukin-2, the company said.  </p>
<p>Four patients in the study discontinued therapy given the extended duration of their remission and their physician's suggestion that they may have a low probability of relapse, Maxim said.</p>
<p>--New York Newsdesk, 212-859-1733</p>
</text>
<copyright>(c) Reuters Limited 1996</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-09-24"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C23">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-09-24"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-09-24"/>
  </code>
</codes>
<dc element="dc.date.created" value="1996-09-24"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1996-09-24"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="SAN DIEGO"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
